Core Viewpoint - The establishment of the Aipeng Medical Artificial Intelligence and Brain-Computer Interface Research Institute marks a significant step in the integration of brain science and AI, aiming to drive innovation in the medical field through advanced technology [1][3]. Group 1: Research Institute and Expert Involvement - The research institute has appointed a group of experts from prestigious institutions to support Aipeng Medical in technology innovation, product implementation, and industry collaboration [3]. - The chairman of Aipeng Medical emphasized the importance of embracing the opportunities presented by AI and brain-computer interface technologies to explore new possibilities at the intersection of technology and clinical applications [3]. Group 2: Market Growth and Focus Areas - The global brain-computer interface market has grown from $1.2 billion in 2019 to nearly $2 billion in 2023, with a compound annual growth rate (CAGR) exceeding 13%, and is projected to reach $7.63 billion by 2029 [5]. - The research institute will focus on three main areas: pain management, anesthesia and sedation, and mental health treatment, aiming to enhance medical service quality and efficiency [5]. Group 3: Clinical Applications and Innovations - Approximately 27% of the global population suffers from sleep disorders, with nearly 300 million affected in China, highlighting the need for innovative solutions in sleep medicine [7]. - Aipeng Medical's new generation ADM anesthesia depth monitor leverages non-invasive EEG technology and AI to provide real-time monitoring and precise staging of sleep, paving the way for intelligent solutions in sleep medicine [7]. - The company is also developing brain-computer interface products for ADHD treatment, utilizing game-based interactive designs to enhance engagement and compliance among children [9]. Group 4: Long-term Technological Innovation - Aipeng Medical has a history of strategic investments in brain-computer interface technologies, including partnerships and product launches since 2019, indicating a systematic approach to this high-barrier field [13]. - The establishment of the research institute aims to bridge the gap between academia and industry, facilitating a collaborative environment for technological advancements [14][16]. - The company plans to leverage the research institute to drive long-term technological innovation and transition from a traditional medical device manufacturer to an AI-driven medical technology platform [16].